Table 3 Total atheroma volume and plaque composition in patients with CAD with HRP and CAD without HRP. N = 203
Variable | CAD with HRP n = 86 | CAD without HRP n = 117 | p-value |
|---|---|---|---|
Vessel length, mm | 209.1 ± 109.0 | 187.5 ± 117.7 | 0.18 |
TAV, mm3 | 867.5 ± 471.1 | 782.7 ± 653.1 | 0.31 |
PAV (%) | 34.4 ± 7.0 | 31.9 ± 10.1 | 0.05 |
Normalized TAV | 745.9 ± 250.6 | 730.7 ± 328.7 | 0.71 |
-Fibrous volume, mm3 | 432.2 ± 152.0 | 449.6 ± 169.4 | 0.45 |
-Fibrous-fatty volume, mm3 | 142.2 ± 63.5 | 108.4 ± 61.6 |  < 0.001 |
-Necrotic core volume, mm3 | 104.5 ± 100.1 | 43.8 ± 76.3 |  < 0.001 |
-Dense calcium volume, mm3 | 64.0 ± 69.4 | 131.1 ± 190.5 | 0.002 |
Coronary stenosis | |||
 Mild (25–49%), n (%) | 68 (79) | 75 (64) | 0.01 |
 Moderate (50–69%), n (%) | 32 (37) | 30 (26) | 0.01 |
 Severe (≥ 70%), n (%) | 3 (3) | 3 (3) | 0.52 |